Variations in Gene Expression and Response to Neoadjuvant Chemotherapy in Breast Carcinoma

被引：5
|
作者：
Boidot, Romain [1 ,4 ]
Vegran, Frederique [1 ,4 ]
Soubeyrand, Marie-Sophie [2 ]
Fumoleau, Pierre [3 ]
Coudert, Bruno [3 ]
Lizard-Nacol, Sarab [1 ,4 ]
机构：
[1] IFR Sante STIC, Mol Genet Lab, Ctr Georges Francois Leclerc, F-21034 Dijon, France
[2] IFR Sante STIC, Pathol Lab, F-21034 Dijon, France
[3] IFR Sante STIC, Dept Oncol, F-21034 Dijon, France
[4] IFR Sante STIC, UMR, INSERM, U866, F-21034 Dijon, France
来源：
CANCER INVESTIGATION | 2009年 / 27卷 / 05期
关键词：
Gene expression; Apoptosis; Cell cycle; Stress; Neoadjuvant chemotherapy; Breast cancer; COMPLETE PATHOLOGICAL RESPONSE; CANCER; DOCETAXEL; PROFILES; DOXORUBICIN; EPIRUBICIN; MICROARRAYS; PREDICTION; APOPTOSIS; TUMORS;
D O I：
10.1080/07357900802298096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this study, we performed a screening of 266 gene expressions in breast carcinomas and carried out correlations with histological response to either FEC-100 (fluorouracil-epirubicin-cyclophosphamide; n = 16) or Tax-Epi (docetaxel-epirubicin; n = 12) treatment. Gene expression in biopsies obtained before and after one course of chemotherapy was analyzed. Expression of specific genes was significantly changed after one course of chemotherapy, particularly for Tax-Epi treatment. Comparison with histological response for both treatments revealed that only good responders exhibited changes in gene-expression profile. These results agree that expression of different genes changes in response to anthracycline-based neoadjuvant chemotherapy and show, for the first time, that response to docetaxel-based treatment implied also changes in gene-expression profile.
引用
收藏
页码：521 / 528
页数：8
相关论文
共 50 条
  • [21] Tumour infiltrating lymphocytes and response to neoadjuvant chemotherapy in invasive breast carcinoma
    Martinez Ortega, M. A.
    Carrillo Garcia, P.
    Rodrigo Lara, H.
    Quintero Duarte, A. M.
    Ballester, A.
    Matheu Capo, G.
    VIRCHOWS ARCHIV, 2017, 471 : S56 - S56
  • [22] Factors predicting complete pathological response to neoadjuvant chemotherapy in breast carcinoma
    Belhadj, O.
    Boudaouara, O.
    Ben Makhlouf, W.
    Triki, M.
    Zghal, M.
    Ayadi, L.
    Boudawara, T. Sellami
    Ben Kridis, W.
    VIRCHOWS ARCHIV, 2024, 485 : S188 - S188
  • [23] Response and outcomes of invasive mucinous carcinoma of the breast after neoadjuvant chemotherapy
    Kir, G.
    Olgun, Z. C.
    Seneldir, H.
    Koca, S.
    Tosun, I.
    Alimoglu, O.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S3 - S3
  • [24] Expression of ERβ gene in breast carcinoma and the relevance in neoadjuvant therapy
    Chang, Jing
    Liu, Jihong
    Li, Huiying
    Li, Jing
    Mu, Yanling
    Feng, Bin
    ONCOLOGY LETTERS, 2017, 13 (03) : 1641 - 1646
  • [25] Gene expression profiles of ovarian serous carcinoma after neoadjuvant chemotherapy
    Shaw, PA
    Agochiya, M
    Sharma, M
    Murphy, J
    Rosen, B
    Brown, TJ
    Begley, H
    Jurisica, I
    LABORATORY INVESTIGATION, 2006, 86 : 195A - 196A
  • [26] Gene expression profiling predicts the therapeutic response of basal-like breast cancers to neoadjuvant chemotherapy
    Lin, Y.
    Lin, S.
    Watson, M.
    Trinkaus, K.
    Fleming, T.
    Weilbaecher, K.
    Naughton, M.
    Aft, R.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 72 - 72
  • [27] Gene expression profiles of ovarian serous carcinoma after neoadjuvant chemotherapy
    Shaw, PA
    Agochiya, M
    Sharma, M
    Murphy, J
    Rosen, B
    Brown, TJ
    Begley, H
    Jurisica, I
    MODERN PATHOLOGY, 2006, 19 : 195A - 196A
  • [28] A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy
    Lin, Yiing
    Lin, Shin
    Watson, Mark
    Trinkaus, Kathryn M.
    Kuo, Sacha
    Naughton, Michael J.
    Weilbaecher, Katherine
    Fleming, Timothy P.
    Aft, Rebecca L.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (03) : 691 - 699
  • [29] A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy
    Yiing Lin
    Shin Lin
    Mark Watson
    Kathryn M. Trinkaus
    Sacha Kuo
    Michael J. Naughton
    Katherine Weilbaecher
    Timothy P. Fleming
    Rebecca L. Aft
    Breast Cancer Research and Treatment, 2010, 123 : 691 - 699
  • [30] Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling
    Shen, Lu-Yan
    Wang, Hui
    Dong, Bin
    Yan, Wan-Pu
    Lin, Yao
    Shi, Qi
    Chen, Ke-Neng
    ONCOTARGET, 2016, 7 (04) : 4531 - 4541
12345